BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.594
-0.076 (-2.07%)
At close: Sep 8, 2025, 4:00 PM
3.540
-0.054 (-1.51%)
After-hours: Sep 8, 2025, 7:19 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $15.39 million as of September 8, 2025. Its market cap has decreased by -75.20% in one year.
Market Cap
15.39M
Enterprise Value
-379.21K
1-Year Change
-75.20%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $15.39M, a decrease of -54.48%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2025 | 16.08M | -31.54% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | 59.85M | 124.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |